Surgery Partners, Inc. SGRY Income Statement

Surgery partners, inc. (SGRY)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Aug'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Sep'14
Revenue from Contract with Customer, Including Assessed Tax
441,000	517,200	452,000	445,400	416,800	491,200	432,400	436,600	411,300	592,600	174,064	288,353	286,183	306,001	282,682	289,681	267,074	263,322	239,599	232,827	224,143	76,303
Operating expenses:
Salaries and benefits
140,400	148,800	139,300	132,700	129,200	139,500	131,400	134,100	129,700	175,400	61,191	90,022	89,887	-	85,724	93,791	86,886	73,280	66,072	62,182	60,151	18,743
Supplies
129,300	143,300	126,200	123,400	115,000	134,600	120,100	121,200	114,400	161,000	48,056	74,084	71,160	-	65,907	66,915	63,662	65,533	60,377	59,087	57,086	17,129
Professional and medical fees
46,800	44,800	38,500	36,400	35,100	38,200	34,900	36,700	35,700	45,100	14,198	22,577	21,125	-	20,856	20,304	19,654	18,439	17,233	16,171	14,740	2,320
Lease expense
21,300	-	-	-	20,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease expense
-	-	21,400	21,000	-	21,800	21,700	21,800	21,400	27,900	9,200	13,674	13,626	-	13,204	13,074	12,434	11,581	11,211	11,096	10,960	3,651
Other operating expenses
28,400	28,500	27,700	26,900	26,200	25,600	26,200	26,300	26,100	32,200	11,155	16,095	16,150	-	15,703	14,768	14,067	14,341	13,928	13,022	12,836	3,534
Cost of revenues
366,200	-	-	-	326,100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenues
-	-	353,100	340,400	-	359,700	334,300	340,100	327,300	441,600	143,800	216,452	211,948	-	201,394	208,852	196,703	183,174	168,821	161,558	155,773	45,377
Total operating expenses
-	-	-	-	-	-	-	-	-	500,300	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative expenses
22,800	23,700	19,900	23,300	21,700	23,900	19,400	26,100	24,200	29,200	12,604	18,655	15,541	-	14,985	15,023	12,197	21,048	11,236	11,846	11,862	6,738
Depreciation, Depletion and Amortization
21,800	20,200	18,400	19,100	18,800	18,000	17,000	16,700	15,700	21,800	7,575	11,417	11,108	-	9,713	9,702	9,568	9,007	8,611	8,465	8,462	2,834
Provision for doubtful accounts (see Note 1)
-	-	-	-	-	-	-	-	-	12,500	4,837	5,788	5,675	-	8,514	3,544	3,873	7,529	5,840	5,023	5,186	1,383
Income from equity investments
2,000	3,600	2,400	2,200	2,000	2,600	1,900	2,500	1,900	3,300	848	1,052	1,200	-	1,167	1,082	758	911	1,320	839	707	0
Gain (Loss) On Disposition Of Assets And Deconsolidation
-3,500	-2,600	-600	8,200	-600	-16,000	-12,600	-3,200	0	0	-99	-405	-1,196	-	-572	-1,331	206	575	-1,161	2,906	-223	8
Transaction and integration costs
5,500	7,400	3,400	6,200	2,000	7,900	7,100	11,700	5,000	7,500	2,359	2,904	337	-	1,864	1,325	3,172	3,023	1,249	8,642	5,006	325
Impairment charges
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on debt extinguishment
-	-	0	-11,700	-	-	0	0	-	0	-18,200	0	0	-	-3,595	0	-8,281	-16,102	0	0	0	0
Litigation settlement
-1,200	-	-	-	0	-	-	-	-	8,700	-	3,794	-	-	-	0	-	-	-	-	-	-
Gain on acquisition escrow release
-	-	-	-	-	-	-	-	-	200	-	-	-	-	-	-	-	-	-	-	-	-
Electronic health records incentive expense (income)
-	-	-	-	-	-	-	-	-	-	-	161	141	-	-364	2	93	1,868	-57	-50	0	0
Other income
-1,500	-1,000	0	-400	0	-200	-1,100	-2,200	-200	-100	-398	0	-2	-	0	40	57	-169	-330	-13	-13	0
Total operating expenses
417,500	-	393,000	389,900	367,200	-	387,400	393,100	370,100	-	-	250,614	244,462	-	239,834	238,733	232,794	242,194	195,325	191,826	185,792	56,649
Operating income
23,500	71,800	59,000	55,500	49,600	-51,900	45,000	43,500	41,200	92,300	-13,460	37,739	41,721	-	42,848	50,948	34,280	21,128	44,274	41,001	38,351	19,654
Tax receivable agreement expense
0	-	0	0	2,400	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on amendment to tax receivable agreement
-	-	-	-	-	-	-	-	-	1,100	-	-	-	-	-	-	-	-	-	-	-	-
Tax receivable agreement (expense) benefit
-	-	-	-	-	-	-	-	-	-25,300	-	-	-	-	3,733	-	-	-	0	-	-	-
Interest expense, net
-47,100	-44,800	-45,700	-46,400	-42,000	-39,600	-37,200	-35,900	-34,300	-48,700	-18,218	-25,600	-25,182	-	-26,475	-26,235	-22,153	-22,473	-26,573	-26,178	-25,756	-11,263
(Loss) income before income taxes
-23,600	27,000	13,300	9,100	5,200	-91,500	7,800	7,600	6,900	70,000	-16,378	12,139	16,539	-	12,640	24,713	12,127	-121,256	17,701	14,823	12,595	8,391
Income tax (benefit) expense
-15,200	4,400	2,400	1,000	1,700	15,500	5,800	3,300	1,800	71,700	-20,729	512	2,117	-	-1,694	2,420	1,770	-157,350	3,917	2,344	2,107	7,961
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-8,400	22,600	10,900	8,100	3,500	-107,000	2,000	4,300	5,100	-1,700	4,351	11,627	14,422	-	14,334	22,293	10,357	36,094	13,784	12,479	10,488	430
Less: Net income attributable to non-controlling interests
19,100	41,800	26,600	27,900	23,600	40,700	23,000	23,800	22,600	39,600	8,826	16,098	17,176	-	16,672	20,173	17,547	19,355	16,906	17,905	17,250	7,338
Net loss attributable to Surgery Partners, Inc.
-27,500	-19,200	-15,700	-19,800	-20,100	-147,700	-21,000	-19,500	-17,500	-41,300	-4,475	-4,471	-2,754	-	-2,338	2,120	-7,190	16,739	-3,122	-5,426	-6,762	-6,908
Less: Amounts attributable to participating securities
9,500	9,300	9,100	8,800	8,500	8,500	8,200	7,900	7,800	26,100	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-37,000	-28,500	-24,800	-28,600	-28,600	-156,200	-29,200	-27,400	-25,300	-67,400	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common stockholders - basic and diluted (in USD per share)
-	-	-	-	-	-	-	-	-	-1.39	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding - basic and diluted (shares)
-	-	-	-	-	-	-	-	-	48,319	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common stockholders
Basic (in USD per share)
-0.76	-	-0.51	-0.59	-0.60	-	-0.61	-0.57	-0.53	-	-	-0.09	-0.06	-	-0.05	0.04	-0.15	0.52	-0.10	-0.17	-0.21	-0.22
Diluted (in USD per share)
-0.76	-	-0.51	-0.59	-0.60	-	-0.61	-0.57	-0.53	-	-	-0.09	-0.06	-	-0.05	0.04	-0.15	0.52	-0.10	-0.17	-0.21	-0.22
Weighted average common shares outstanding
Basic (shares)
48,472	-	48,310	48,291	48,047	-	48,038	48,016	48,007	-	-	48,145	48,019	-	48,019	48,019	48,017	48,102	32,054	32,054	32,054	31,698
Diluted (shares)
48,472	-	48,310	48,291	48,047	-	48,038	48,016	48,007	-	-	48,145	48,019	-	48,019	48,129	48,017	53,695	32,054	32,054	32,054	31,698
Contingent acquisition expense
-	-	-	-	-	-	-	-	-	-	-	1,814	-	-	-	1,530	-	-	-	-	-	-